Congenital coronary anomalies and surgical treatment

Nihan Kayalar1, Harold M Burkhart, Joseph A Dearani

  • 1Division of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn 55905, USA.

Congenital Heart Disease
|August 12, 2009
PubMed

Insights

Coronary artery anomalies affect 1.3% of people and can cause serious issues like sudden death. Early diagnosis and treatment are crucial for potentially life-threatening conditions.

Area of Science:

  • Cardiology
  • Congenital Heart Disease

Background:

  • Coronary artery anomalies (CAAs) are relatively common, found in 1.3% of the population.
  • While often incidental, approximately 20% of CAAs carry risks of severe complications like myocardial infarction, arrhythmia, or sudden death.
  • CAAs encompass diverse conditions, some requiring intervention only when symptomatic or during other cardiac surgeries.

Purpose of the Study:

  • To highlight the clinical significance of various coronary artery anomalies.
  • To emphasize the importance of considering CAAs in the differential diagnosis of cardiac symptoms, particularly in younger individuals.
  • To advocate for increased awareness for earlier diagnosis and management of potentially life-threatening CAAs.

Main Methods:

  • Review of existing literature on coronary artery anomalies.
  • Analysis of the clinical presentation and management strategies for different types of CAAs.
  • Discussion of diagnostic considerations for CAAs in patients presenting with cardiac symptoms.

Main Results:

  • Certain CAAs, like anomalous origin of the left coronary artery from the pulmonary artery or the opposite sinus with inter-arterial course, necessitate surgical correction.
  • Other anomalies such as coronary artery fistulas, myocardial bridging, and coronary aneurysms require intervention only when symptomatic.
  • CAAs should be considered in the differential diagnosis of anginal symptoms, myocardial infarction, arrhythmia, or heart failure, especially in young patients.

Conclusions:

  • Increased awareness of CAAs can lead to earlier diagnosis and timely treatment.
  • Prompt recognition and management of CAAs are vital for preventing severe, life-threatening complications.
  • A comprehensive understanding of CAA spectrum is essential for effective patient care.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...